Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Noninvasive Immunohistochemical Diagnosis and Novel MUC1 Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease

M. Živná, K. Kidd, A. Přistoupilová, V. Barešová, M. DeFelice, B. Blumenstiel, M. Harden, P. Conlon, P. Lavin, DM. Connaughton, H. Hartmannová, K. Hodaňová, V. Stránecký, A. Vrbacká, P. Vyleťal, J. Živný, M. Votruba, J. Sovová, H. Hůlková, V....

. 2018 ; 29 (9) : 2418-2431. [pub] 20180702

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19035151

Grantová podpora
NV17-29786A MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek

E-zdroje Online Plný text

NLK Free Medical Journals od 1990 do Před 1 rokem
PubMed Central od 2008 do Před 1 rokem
Europe PubMed Central od 2008 do Před 1 rokem
Open Access Digital Library od 1990-07-01

BACKGROUND: Autosomal dominant tubulointerstitial kidney disease caused by mucin-1 gene (MUC1) mutations (ADTKD-MUC1) is characterized by progressive kidney failure. Genetic evaluation for ADTKD-MUC1 specifically tests for a cytosine duplication that creates a unique frameshift protein (MUC1fs). Our goal was to develop immunohistochemical methods to detect the MUC1fs created by the cytosine duplication and, possibly, by other similar frameshift mutations and to identify novel MUC1 mutations in individuals with positive immunohistochemical staining for the MUC1fs protein. METHODS: We performed MUC1fs immunostaining on urinary cell smears and various tissues from ADTKD-MUC1-positive and -negative controls as well as in individuals from 37 ADTKD families that were negative for mutations in known ADTKD genes. We used novel analytic methods to identify MUC1 frameshift mutations. RESULTS: After technique refinement, the sensitivity and specificity for MUC1fs immunostaining of urinary cell smears were 94.2% and 88.6%, respectively. Further genetic testing on 17 families with positive MUC1fs immunostaining revealed six families with five novel MUC1 frameshift mutations that all predict production of the identical MUC1fs protein. CONCLUSIONS: We developed a noninvasive immunohistochemical method to detect MUC1fs that, after further validation, may be useful in the future for diagnostic testing. Production of the MUC1fs protein may be central to the pathogenesis of ADTKD-MUC1.

Broad Institute of Harvard and Massachusetts Institute of Technology Cambridge Massachusetts

Broad Institute of Harvard and Massachusetts Institute of Technology Cambridge Massachusetts Department of Medicine Brigham and Women's Hospital Boston Massachusetts

Center for Molecular Medicine Cologne University of Cologne Cologne Germany Institute of Human Genetics University Hospital of Cologne Cologne Germany

Department of Medicine Harvard Medical School Boston Massachusetts

Department of Nephrology Beaumont Hospital Dublin Ireland Royal College of Surgeons Dublin Ireland

Department of Nephrology Beaumont Hospital Dublin Ireland Trinity Health Kidney Centre Tallaght Hospital Dublin Ireland

Department of Paediatrics 2nd Faculty of Medicine Charles University Prague Czech Republic

Division of Nephrology and Vascular Biology Research Center Beth Israel Deaconess Medical Center Boston Massachusetts

Institute of Pathophysiology 1st Faculty of Medicine

Molecular Medicine Research Center Department of Biological Sciences University of Cyprus Nicosia Cyprus

Nephrology Department Institute for Clinical and Experimental Medicine Prague Czech Republic

Research Unit for Rare Diseases Department of Pediatrics and Adolescent Medicine 1st Faculty of Medicine

Research Unit for Rare Diseases Department of Pediatrics and Adolescent Medicine 1st Faculty of Medicine Institute of Pathology 1st Faculty of Medicine and

Research Unit for Rare Diseases Department of Pediatrics and Adolescent Medicine 1st Faculty of Medicine Section on Nephrology Wake Forest School of Medicine Winston Salem North Carolina

Section on Nephrology Wake Forest School of Medicine Winston Salem North Carolina

Trinity Health Kidney Centre Tallaght Hospital Dublin Ireland

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035151
003      
CZ-PrNML
005      
20191014131739.0
007      
ta
008      
191007s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1681/ASN.2018020180 $2 doi
035    __
$a (PubMed)29967284
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Živná, Martina $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine.
245    10
$a Noninvasive Immunohistochemical Diagnosis and Novel MUC1 Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease / $c M. Živná, K. Kidd, A. Přistoupilová, V. Barešová, M. DeFelice, B. Blumenstiel, M. Harden, P. Conlon, P. Lavin, DM. Connaughton, H. Hartmannová, K. Hodaňová, V. Stránecký, A. Vrbacká, P. Vyleťal, J. Živný, M. Votruba, J. Sovová, H. Hůlková, V. Robins, R. Perry, A. Wenzel, BB. Beck, T. Seeman, O. Viklický, S. Rajnochová-Bloudíčková, G. Papagregoriou, CC. Deltas, SL. Alper, A. Greka, AJ. Bleyer, S. Kmoch,
520    9_
$a BACKGROUND: Autosomal dominant tubulointerstitial kidney disease caused by mucin-1 gene (MUC1) mutations (ADTKD-MUC1) is characterized by progressive kidney failure. Genetic evaluation for ADTKD-MUC1 specifically tests for a cytosine duplication that creates a unique frameshift protein (MUC1fs). Our goal was to develop immunohistochemical methods to detect the MUC1fs created by the cytosine duplication and, possibly, by other similar frameshift mutations and to identify novel MUC1 mutations in individuals with positive immunohistochemical staining for the MUC1fs protein. METHODS: We performed MUC1fs immunostaining on urinary cell smears and various tissues from ADTKD-MUC1-positive and -negative controls as well as in individuals from 37 ADTKD families that were negative for mutations in known ADTKD genes. We used novel analytic methods to identify MUC1 frameshift mutations. RESULTS: After technique refinement, the sensitivity and specificity for MUC1fs immunostaining of urinary cell smears were 94.2% and 88.6%, respectively. Further genetic testing on 17 families with positive MUC1fs immunostaining revealed six families with five novel MUC1 frameshift mutations that all predict production of the identical MUC1fs protein. CONCLUSIONS: We developed a noninvasive immunohistochemical method to detect MUC1fs that, after further validation, may be useful in the future for diagnostic testing. Production of the MUC1fs protein may be central to the pathogenesis of ADTKD-MUC1.
650    _2
$a jehlová biopsie $7 D001707
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $x epidemiologie $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    _2
$a incidence $7 D015994
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mucin 1 $x genetika $7 D018396
650    _2
$a mutace $x genetika $7 D009154
650    _2
$a rodokmen $7 D010375
650    _2
$a polycystické ledviny autozomálně dominantní $x genetika $x mortalita $x patologie $7 D016891
650    _2
$a prognóza $7 D011379
650    _2
$a registrace $7 D012042
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a hodnocení rizik $7 D018570
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kidd, Kendrah $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
700    1_
$a Přistoupilová, Anna $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine.
700    1_
$a Barešová, Veronika $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine.
700    1_
$a DeFelice, Mathew $u Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.
700    1_
$a Blumenstiel, Brendan $u Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.
700    1_
$a Harden, Maegan $u Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.
700    1_
$a Conlon, Peter $u Department of Nephrology, Beaumont Hospital, Dublin, Ireland. Royal College of Surgeons, Dublin, Ireland.
700    1_
$a Lavin, Peter $u Trinity Health Kidney Centre, Tallaght Hospital, Dublin, Ireland.
700    1_
$a Connaughton, Dervla M $u Department of Nephrology, Beaumont Hospital, Dublin, Ireland. Trinity Health Kidney Centre, Tallaght Hospital, Dublin, Ireland.
700    1_
$a Hartmannová, Hana $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine.
700    1_
$a Hodaňová, Kateřina $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine.
700    1_
$a Stránecký, Viktor $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine.
700    1_
$a Vrbacká, Alena $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine.
700    1_
$a Vyleťal, Petr $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine.
700    1_
$a Živný, Jan $u Institute of Pathophysiology, First Faculty of Medicine.
700    1_
$a Votruba, Miroslav $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine.
700    1_
$a Sovová, Jana $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine.
700    1_
$a Hůlková, Helena $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine. Institute of Pathology, First Faculty of Medicine, and.
700    1_
$a Robins, Victoria $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
700    1_
$a Perry, Rebecca $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
700    1_
$a Wenzel, Andrea $u Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany. Institute of Human Genetics, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Beck, Bodo B $u Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany. Institute of Human Genetics, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Seeman, Tomáš $u Department of Paediatrics, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Viklický, Ondřej $u Nephrology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Rajnochová-Bloudíčková, Sylvie $u Nephrology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Papagregoriou, Gregory $u Molecular Medicine Research Center, Department of Biological Sciences, University of Cyprus, Nicosia, Cyprus.
700    1_
$a Deltas, Constantinos C $u Molecular Medicine Research Center, Department of Biological Sciences, University of Cyprus, Nicosia, Cyprus.
700    1_
$a Alper, Seth L $u Division of Nephrology and Vascular Biology Research Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
700    1_
$a Greka, Anna $u Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; and. Department of Medicine, Harvard Medical School, Boston, Massachusetts.
700    1_
$a Bleyer, Anthony J $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, ableyer@wakehealth.edu. Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
700    1_
$a Kmoch, Stanislav $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine. Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
773    0_
$w MED00002977 $t Journal of the American Society of Nephrology : JASN $x 1533-3450 $g Roč. 29, č. 9 (2018), s. 2418-2431
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29967284 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191014132203 $b ABA008
999    __
$a ok $b bmc $g 1451811 $s 1073701
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 29 $c 9 $d 2418-2431 $e 20180702 $i 1533-3450 $m Journal of the American Society of Nephrology $n J Am Soc Nephrol $x MED00002977
GRA    __
$a NV17-29786A $p MZ0
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...